Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-012475
Filing Date
2018-02-22
Accepted
2018-02-22 16:43:33
Documents
1
Period of Report
2018-02-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7088
  Complete submission text file 0001209191-18-012475.txt   8648
Mailing Address 1212 TERRA BELLA AVENUE MOUNTAIN VIEW CA 94043
Business Address
MAKOWER JOSHUA (Reporting) CIK: 0001235952 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 18633156

Mailing Address 3101 WESTERN AVE. SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVE. SUITE 600 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Issuer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research